NCT01562171
- Conditions
- Body Weight, Dyslipidemias, Hypercholesterolemia, +10 more
- Locations
-
- I.H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada
- Glycemic Index Laboratories, Incorporated Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Obesity. Study availability and eligibility vary by location and protocol.
NCT01562171
NCT02044731
NCT01665742
NCT01200459
NCT01134029
NCT00870259
NCT02309034
Not specified
NCT01645995
NCT01622309
NCT00510588